Hong Kong Stocks Surging | Xianruida Medical-B (06669.HK) Rises Over 4% Recently AcoArt Canna, a drug-coated coronary balloon dilation catheter, has been approved for registration.

According to the Securities Times app, Sinocare Inc. Class B (06669.HK) has risen by more than 4%, with an increase of 4.63% to HK$11.97 as of press time, with a trading volume of HK$6.2497 million.